跳至主要内容
临床试验/EUCTR2013-004629-96-DK
EUCTR2013-004629-96-DK进行中(未招募)不适用

Diagnostic Modalities in Nuclear Medicine in Well-Differentiated Thyroid Cancer - DIAMONDT

Department of Nuclear Medicine, Odense University Hospital0 个研究点目标入组 100 人开始时间: 2014年4月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients with well-differentiated thyroid carcinoma referred for I-131 radioiodine therapy
  • - 18 years or older
  • - Written consent form
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 40

排除标准

  • - Pregnancy or breast feeding
  • - Inability to comply with instructions
  • - A body weight greater than 150 kg.
  • - Reduced kidney function (defined as increased S-Creatinine or diagnosed kidney disease).
  • - Lactose intolerance
  • - Leukopenia, urinary incontinence, dysphagia, oesophageal stricture, active gastritis, gastric erosions and peptic ulcer and suspected reduced gastrointestinal motility

研究者

发起方
Department of Nuclear Medicine, Odense University Hospital

相似试验